Journey Medical (DERM) Common Equity (2020 - 2025)
Historic Common Equity for Journey Medical (DERM) over the last 6 years, with Q3 2025 value amounting to $25.9 million.
- Journey Medical's Common Equity rose 13703.09% to $25.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.9 million, marking a year-over-year increase of 13703.09%. This contributed to the annual value of $20.1 million for FY2024, which is 138.08% down from last year.
- According to the latest figures from Q3 2025, Journey Medical's Common Equity is $25.9 million, which was up 13703.09% from $19.2 million recorded in Q2 2025.
- Journey Medical's Common Equity's 5-year high stood at $42.0 million during Q4 2021, with a 5-year trough of -$11.7 million in Q3 2021.
- Its 5-year average for Common Equity is $18.6 million, with a median of $19.2 million in 2025.
- Per our database at Business Quant, Journey Medical's Common Equity tumbled by 27161.07% in 2021 and then surged by 22580000.0% in 2024.
- Journey Medical's Common Equity (Quarter) stood at $42.0 million in 2021, then crashed by 59.61% to $17.0 million in 2022, then grew by 19.83% to $20.3 million in 2023, then dropped by 1.38% to $20.1 million in 2024, then rose by 29.04% to $25.9 million in 2025.
- Its last three reported values are $25.9 million in Q3 2025, $19.2 million for Q2 2025, and $21.5 million during Q1 2025.